We are live on ! Find out more
ACM

Atika Capital Management Portfolio holdings

AUM $796M
1-Year Est. Return 167.57%
This Fund
S&P 500
This Quarter Est. Return
+29.3%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$520M
AUM Growth
+$228M
Cap. Flow
+$160M
Cap. Flow %
30.79%
Top 10 Hldgs %
35.42%
Holding
109
New
39
Increased
20
Reduced
26
Closed
22

Top Buys

Rank Stock Value
1
WW
WW International
WW
+$9.43M
2
PVTL
Pivotal Software, Inc.
PVTL
+$6.7M
3
ASH icon
Ashland
ASH
+$6.33M
4
GRA
W.R. Grace & Co.
GRA
+$6.24M
5
ROKU icon
Roku
ROKU
+$5.84M

Top Sells

Rank Stock Value
1
TEAM icon
Atlassian
TEAM
+$6.15M
2
GS icon
Goldman Sachs
GS
+$5.92M
3
AVXS
AveXis, Inc. Common Stock
AVXS
+$4.94M
4
RHT
Red Hat Inc
RHT
+$4.19M
5
SAGE
Sage Therapeutics
SAGE
+$3.46M

Sector Composition

Rank Sector Weight
1 Healthcare 26.36%
2 Technology 14.26%
3 Communication Services 11.83%
4 Consumer Discretionary 10.15%
5 Materials 3.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRTX icon
76
Vertex Pharmaceuticals
VRTX
$119B
$2.04M 0.39%
12,000
-3,000
-20% -$465K
MNTA
77
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$1.82M 0.35%
+89,000
New +$1.91M
VEEV icon
78
Veeva Systems
VEEV
$33.5B
$1.54M 0.3%
20,000
-5,000
-20% -$380K
FWONK icon
79
CALL
Liberty Media Series C
FWONK
$24.5B
$1.49M 0.29%
+41,372
New +$1.26M
ATVI
80
DELISTED
Activision Blizzard
ATVI
$1.37M 0.26%
18,000
-14,000
-44% -$991K
SAIL
81
PUT
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
$1.23M 0.24%
+50,000
New +$1.22M
CRSP icon
82
CALL
CRISPR Therapeutics
CRSP
$4.88B
$1.18M 0.23%
+20,000
New +$1.14M
ASND icon
83
Ascendis Pharma A/S
ASND
$16B
$1.04M 0.2%
+15,700
New +$1.03M
CRTO icon
84
PUT
Criteo S.A. Ordinary Shares
CRTO
$1.07B
$986K 0.19%
+30,000
New +$827K
ARNA
85
CALL
DELISTED
Arena Pharmaceuticals Inc
ARNA
$815K 0.16%
+18,700
New +$804K
SGI
86
CALL
Somnigroup International
SGI
$14B
$721K 0.14%
60,000
– –
RHT
87
DELISTED
Red Hat Inc
RHT
$671K 0.13%
5,000
-26,000
-84% -$4.19M
MDCO
88
DELISTED
Medicines Co
MDCO
$396K 0.08%
+10,813
New +$351K
ABBV icon
89
AbbVie
ABBV
$433B
– –
-25,000
Closed -$2.37M
ADBE icon
90
Adobe
ADBE
$99.9B
– –
-5,000
Closed -$1.08M
ADVM
91
DELISTED
Adverum Biotechnologies
ADVM
– –
-19,500
Closed -$1.13M
AZUL
92
DELISTED
Azul
AZUL
– –
-85,000
Closed -$2.95M
CGNX icon
93
Cognex
CGNX
$11.2B
– –
-32,000
Closed -$1.66M
CMA
94
DELISTED
Comerica
CMA
– –
-21,000
Closed -$2.02M
CTSH icon
95
PUT
Cognizant
CTSH
$24.9B
– –
-78,500
Closed -$6.32M
DBI icon
96
Designer Brands
DBI
$331M
– –
-96,000
Closed -$2.16M
ESPR
97
DELISTED
Esperion Therapeutics
ESPR
– –
-40,000
Closed -$2.89M
FOLD
98
DELISTED
Amicus Therapeutics
FOLD
– –
-100,000
Closed -$1.5M
GS icon
99
Goldman Sachs
GS
$303B
– –
-23,500
Closed -$5.92M
INCY icon
100
PUT
Incyte
INCY
$24B
– –
-72,500
Closed -$6.04M
1 2 3
4
5

Similar funds

AGA
Arkos Global Advisors Houston, Texas $797M AUM 15.28% 1-Year Est. Return
RIM
Rovida Investment Management Grand Cayman, Cayman Islands $797M AUM 111.83% 1-Year Est. Return
ACM
Ashe Capital Management Englewood Cliffs, New Jersey $797M AUM 4.79% 1-Year Est. Return
CAM
CenterStar Asset Management Chicago, Illinois $797M AUM 28.71% 1-Year Est. Return
Legacy Financial Group (Iowa)
Legacy Financial Group (Iowa) Des Moines, Iowa $795M AUM 12.87% 1-Year Est. Return
LSA
L & S Advisors Los Angeles, California $795M AUM 52.77% 1-Year Est. Return
GWA
Geometric Wealth Advisors Washington, District of Columbia $799M AUM 22.19% 1-Year Est. Return
HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return

Atika Capital Management's Q2 2018 Portfolio in Review

As of Q2 2018, Atika Capital Management held 109 positions worth $520M, up 78% from $292M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Atika Capital Management deployed $160M of net new capital in Q2 2018, opening 39 new positions and adding to 20 existing holdings. Its largest new stake was WW International: 120,000 shares worth $12.1M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 33% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Red Hat Inc, an estimated $4.19M trimmed.

  • Atika Capital Management's largest Q2 2018 buy was WW International: 120,000 shares worth $12.1M.
  • Atika Capital Management added most to Exact Sciences in Q2 2018, an estimated $5.19M increase.
  • Atika Capital Management's biggest Q2 2018 reduction was Red Hat Inc, cutting an estimated $4.19M.
  • Atika Capital Management fully exited Atlassian in Q2 2018, selling an estimated $6.15M.
  • Atika Capital Management's ten largest holdings make up 35% of its $520M portfolio in Q2 2018.
  • Atika Capital Management opened 39 new positions and closed 22 in Q2 2018.
  • Atika Capital Management's portfolio value rose 78% quarter-over-quarter to $520M.

Based on Atika Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.